Delivery Order SPE2DX19D5041-SPE2DX23FEZWH
Award Date 12/7/22
Potential Completion Date 12/29/22
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 27, 2026, for VABYSMO 6 mg/0.05 ml vials with a ceiling value of $3,593.55 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, with a ceiling value of $1,799.50 for Flumazenil 0.1 mg/ml vial 5ml, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 17, 2026, for JAKAFI 10 mg tablets (60-count), with a ceiling value of $75,979.68 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical is the sole...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 16, 2026, for VABYSMO 6 mg/0.05 ml vials with a ceiling value of $7,187.10 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. DMS...
- The Defense Logistics Agency issued a $4,389 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for Fasenra pen 30 mg/ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a $19,759.23 delivery order to DMS Pharmaceutical Group Inc. on May 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for FIRDAPSE 10 mg tablets. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 23, 2026, for JAKAFI 10 mg tablets (60-count) with a ceiling value of $12,663.27, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a single-award indefinite delivery contract under which DMS Pharmaceutical serves as the sole regional prime vendor for pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities...
- This is a $4,985.04 firm-fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The order is for "SYFOVRE 15 MG/0.1 ML VIAL 0.1ML" and has a completion date of July 22, 2024. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. This...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, with a ceiling value of $6,142.92, for FASENRA PEN 30 MG/ML under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS...